Clinical Evaluation of Pushkarmoola Arka Nebulization in Tamak Shwasa

Abstract

In Ayurveda, Tamak Shwasa is included under the spectrum of Shwasa Roga and is predominantly manifested by recurrent episodes of marked respiratory distress associated with a sense of suffocation. The etiopathogenesis of this condition is explained as the simultaneous vitiation of Pranavayu and Kapha Dosha, which localize in the pulmonary region and produce obstruction within the Pranavaha Srotasa (channels responsible for respiration). Owing to similarity in clinical presentation, Tamak Shwasa can be correlated with bronchial asthma described in contemporary medical literature. Numerous formulations derived from medicinal plants have been documented in classical Ayurvedic treatises for the management of Tamak Shwasa. In recent times, nebulization has emerged as an effective aerosol-based drug delivery modality in the treatment of bronchial asthma. This method enables direct deposition of micronized liquid medication into the airways, thereby facilitating rapid alleviation of acute respiratory symptoms. Compared to oral administration, nebulization offers improved patient compliance, eliminates concerns related to taste, and is especially advantageous in paediatric populations. Furthermore, localized drug delivery ensures a quicker therapeutic response due to direct action at the site of pathology. Considering these factors, the present clinical study was designed to assess the safety and therapeutic potential of Pushkarmoola Arka administered through nebulization in patients of Tamak Shwasa (bronchial asthma). Pushkarmoola is described as possessing Katu and Tikta Rasa, Laghu and Tikshna Guna, Ushna Virya, and Katu Vipaka, and is traditionally recognized for its Kapha–Vata Shamana properties. When prepared as a water-based Arka and delivered via nebulization, the formulation is anticipated to exert prompt symptomatic relief by directly influencing the respiratory tract, which represents the principal locus of disease manifestation.